Severe Respiratory Infections: Underestimated Incidence?

Global respiratory disease surveillance may be significantly undercounting infections in young children, according to a newly published meta-analysis. The study, appearing in JAMA Network Open, reveals that the World Health Organization’s (WHO) standard definition for Severe Acute Respiratory Infection (SARI) is surprisingly poor at identifying cases of influenza and RSV – the two viruses most commonly assessed – particularly in children under five. This isn’t merely an academic exercise; inaccurate surveillance data directly impacts pandemic preparedness and resource allocation.

The Problem with Counting Cases

For decades, public health organizations have relied on SARI surveillance to track the spread of respiratory viruses and estimate their impact. The WHO’s SARI definition – which focuses on fever and cough, among other symptoms – is used globally as a baseline for monitoring. However, this study, encompassing data from nearly 65 hospitals across eight countries between 2007 and 2023, demonstrates that this definition misses a substantial number of actual cases, especially in young children. The meta-analysis found the WHO 2014 SARI definition yielded a sensitivity of 75.7% and specificity of 30.6% for flu and a sensitivity of 70.6% and specificity of 38.7% for RSV. Lower sensitivity means more false negatives – sick children being missed by the system.

This isn’t simply about refining definitions for the sake of accuracy. Underreporting the true burden of respiratory illness has cascading effects. It can lead to underestimation of hospitalization rates, misallocation of vaccines and antiviral medications, and a delayed or inadequate response to emerging outbreaks. The researchers specifically point to the importance of accurate data for pandemic preparedness, a lesson painfully learned during the initial stages of the COVID-19 pandemic.

Looking Ahead: What Needs to Change?

The study’s authors rightly emphasize the need for a more nuanced approach to pediatric respiratory disease surveillance. The findings suggest that relying solely on SARI case definitions can lead to a significant underestimation of disease burden, particularly in young children. Adjustments to incidence calculations are needed to account for the inherent limitations of the current case definitions.

However, the most pressing need is to expand the scope of surveillance to include a broader range of pathogens, most notably SARS-CoV-2. The near-complete absence of COVID-19 data in the analyzed studies is a glaring omission, given the virus’s demonstrated ability to cause severe respiratory illness in children. We can expect to see increased pressure on the WHO and national health agencies to incorporate more comprehensive testing protocols and refine case definitions to better capture the full spectrum of respiratory viruses circulating in pediatric populations.

What to watch: Expect a surge in research focused on developing and validating more accurate surveillance tools for pediatric respiratory infections. This will likely involve integrating molecular diagnostics (PCR testing) with clinical data and exploring alternative case definitions that are more sensitive and specific for different age groups and viral pathogens. Furthermore, the findings will likely fuel debate about the optimal strategies for vaccine prioritization and resource allocation during future respiratory disease outbreaks.